|
UCLA Launches New Institute of Urologic Oncology |
|
Written by Kim Irwin
|
|
Friday, 06 March 2009 |
|
Los Angeles, California - UCLA has launched a first-of-its-kind, patient-centered institute dedicated to developing leading-edge therapies for the treatment of kidney, bladder, testicular and prostate cancers.
|
|
Read more...
|
|
|
Developing Orphan Products: FDA and Rare Disease Day |
|
Written by IV Post
|
|
Wednesday, 04 March 2009 |
|
Washington, DC - Organizations around the world are observing February 28, 2009, as the 2nd annual World Rare Disease Day - an important time for bringing attention to the needs of people with rare diseases. |
|
Read more...
|
|
|
Guide to Safe Use of Pain Medicine |
|
Written by FDA
|
|
Wednesday, 04 March 2009 |
|
Washington, DC - If you've ever been treated for severe pain from surgery, an injury, or an illness, you know just how vital pain relief medications can be. Pain relief treatments come in many forms and potencies, are available by prescription or over-the-counter (OTC), and treat all sorts of physical pain including that brought on by chronic conditions, sudden trauma, and cancer.
|
|
Read more...
|
|
|
Reducing Radiation from Medical X-rays |
|
Written by FDA
|
|
Wednesday, 04 March 2009 |
|
Washington, DC - One of medicine's most remarkable achievements is the use of X-rays to see inside the body without having a surgeon wield a scalpel. |
|
Read more...
|
|
|
Improper Use of Skin Numbing Products Can Be Deadly |
|
Written by FDA
|
|
Wednesday, 04 March 2009 |
|
Washington, DC - In January 2009, the Food and Drug Administration (FDA) issued a public health advisory about the improper use of skin numbing products. Also known as topical anesthetics, these products have been used to lessen pain in certain procedures such as skin treatments and laser hair removal. |
|
Read more...
|
|
|
FDA Takes Action Against KV Pharmaceutical Company |
|
Written by San Diego Newscape
|
|
Tuesday, 03 March 2009 |
|
The FDA announced a Consent Decree of permanent injunction filed March 2, 2009, enjoining KV Pharmaceutical Company, its subsidiaries ETHEX Corporation and Ther-Rx Corporation, and its principal officers from making and distributing adulterated and unapproved drugs. The injunction against KV and the other defendants, once entered by the court, will prevent them from manufacturing and shipping drugs until the firm obtains FDA approval. |
|
Read more...
|
|
|
Governor Schwarzenegger on President Obama Selecting Kathleen Sebelius for Health and Human Services |
|
Written by IV Post
|
|
Monday, 02 March 2009 |
|
Sacramento, California - California Governor Arnold Schwarzenegger today issued a statement following President Obama’s selection of Kansas Governor Kathleen Sebelius for Secretary of Health and Human Services: |
|
Read more...
|
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
|
| Results 109 - 120 of 614 |